AKT1 and hepatocellular carcinoma: In human HCC specimens, nuclear translocation of SKP2, was associated with activation of the AKT/mTOR and RAS/RAF/MAPK pathways to promote hepatocarcinogenesis in vivo (Delogu et al., 2015).